Universe Pharmaceuticals (UPC) Receivables - Other (2021 - 2025)
Universe Pharmaceuticals (UPC) has disclosed Receivables - Other for 4 consecutive years, with $2.3 billion as the latest value for Q3 2025.
- Quarterly Receivables - Other fell 35.98% to $2.3 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.3 billion through Sep 2025, down 35.98% year-over-year, with the annual reading at $2.3 billion for FY2025, 35.98% down from the prior year.
- Receivables - Other hit $2.3 billion in Q3 2025 for Universe Pharmaceuticals, down from $3.6 billion in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $3.6 billion in Q3 2024 to a low of $236982.0 in Q3 2021.
- Historically, Receivables - Other has averaged $1.5 billion across 4 years, with a median of $1.1 billion in 2023.
- Biggest five-year swings in Receivables - Other: soared 185421.16% in 2024 and later tumbled 35.98% in 2025.
- Year by year, Receivables - Other stood at $236982.0 in 2021, then soared by 710.29% to $1.9 million in 2023, then skyrocketed by 185421.16% to $3.6 billion in 2024, then crashed by 35.98% to $2.3 billion in 2025.
- Business Quant data shows Receivables - Other for UPC at $2.3 billion in Q3 2025, $3.6 billion in Q3 2024, and $1.9 million in Q3 2023.